CEFOTAXIME sodium, eq. 500mg base, vial
STD
DINJCEFO5V-
Valid Article
Account code:
60000
HS Code:
300420
Last Updated on:
28/07/2024, 22:00:36
6.2.2 - Watch group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01DD01
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
CEFOTAXIME
Therapeutic Action
Third generation cephalosporin antibacterial
Indications
In hospitalised neonates:
Bacterial meningitis, in combination with another antibacterial
Gonococcal conjunctivitis
- See: Essential drugs, MSF, 2024
- See: Clinical guidelines, MSF, 2024
- See: Neonatal care, Clinical and Therapeutic guidelines, MSF, 2021
- See: Pathogen-Specific, Targeted Antibiotic Therapy for Bacteremia and Bone and Joint, Urinary Tract, and Central Nervous System Infections. MSF internal protocol, 2019
Instructions for use
- IM or slow IV injection (3 to 5 minutes): reconstitute the powder vial with 2 ml water for injection.
- IV infusion (20 to 60 minutes): reconstitute the powder vial in 0.9% NaCl or 5% dextrose.
For pneumonia in neonates, prefer ampicillin + gentamicin.
For gonococcal conjunctivitis in neonates, use cefotaxime only if ceftriaxone is not available or contraindicated.
Storage
Below 25°C - Protect from sunlight